Contribution of limbic norepinephrine to cannabinoid-induced aversion

RATIONALE: The cannabinoid system has risen to the forefront in the development of novel treatments for a number of pathophysiological processes. However, significant side effects have been observed in clinical trials raising concerns regarding the potential clinical utility of cannabinoid-based age...

Full description

Bibliographic Details
Main Author: Carvalho, Ana Raquel Franky Gomes (author)
Other Authors: Reyes, Arith-Ruth S. (author), Sterling, Robert C. (author), Unterwald, Ellen (author), Bockstaele, Elisabeth J. Van (author)
Format: article
Language:eng
Published: 2010
Subjects:
Online Access:http://hdl.handle.net/1822/29625
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/29625